Aayush Wellness has fixed 26 December 2024 as record date for purpose of determining the equity shareholders of the Company eligible for bonus equity shares.Powered by Capital Market - Live

Under the terms of the agreement, the company will provide its flagship nutraceutical products to cater to Singapore's growing demand for high-quality dietary supplements. These products include effervescent tablets, marine collagen, probiotics, super greens powders, and more. The supply will be delivered over the next year. This order marks a significant milestone for Aayush Wellness Limited and marks its entry on a global nutraceuticals and healthcare market. Singapore's health supplements market is estimated to be worth US $ 202.8 million in 2024 and its annual growth rate is projected to be 3.81% p.a. Naveena Kumar, managing director of the company said that 'The success our product in India has laid foundation for the company's foray into international markets, starting with Singapore a hub for health-conscious consumers. This is company's first export order and mark's the company entry in the premium Singaporean market. This shall have a substantial impact of the company operational performance and expansion plans by developing the export market for our products.' Aayush Wellness is engaged provides health and wellness solutions. The company manufactures and exports nutraceuticals, supplements, healthy food, and enriching solutions by redefining typical practices. The company reported standalone net profit of Rs 92 lakh in Q2 FY25 as against Rs 28 lakh posted in the Q2 FY24. Revenue from operations surged to Rs 14.28 lakh in Q2 FY25 as compared to Rs 60 lakh recorded in Q2 FY24. The scrip hit an all time high of Rs 180.55 in intraday today. As of 12 December 2024, the company's market capitalization stood at Rs 585.88 crore on the BSE. Powered by Capital Market - Live

Net profit of Aayush Wellness rose 228.57% to Rs 0.92 crore in the quarter ended September 2024 as against Rs 0.28 crore during the previous quarter ended September 2023. Sales rose 2280.00% to Rs 14.28 crore in the quarter ended September 2024 as against Rs 0.60 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales14.280.60 2280 OPM %6.4440.00 - PBDT0.920.28 229 PBT0.920.28 229 NP0.920.28 229 Powered by Capital Market - Live

Aayush Wellness will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

The Board of Aayush Wellness on 29th October 2024 has approved Issue of 1,62,25,000 Bonus equity shares in the ratio of 1:2 i.e. 1 (One) fully paid-up equity share for every 2 (Two) existing equity share having face value of Rs. 1/- (Rupee One only) each, held by the members of the Company as on Record Date, subject to necessary approvals as may be required. Powered by Capital Market - Live

Aayush Wellness will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live

Aayush Wellness announced that the 40th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

Net profit of Aayush Wellness rose 177.78% to Rs 0.25 crore in the quarter ended June 2024 as against Rs 0.09 crore during the previous quarter ended June 2023. Sales reported to Rs 11.08 crore in the quarter ended June 2024. There were no Sales reported during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales11.080 0 OPM %2.080 - PBDT0.250.09 178 PBT0.250.09 178 NP0.250.09 178 Powered by Capital Market - Live

Aayush Wellness will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live